Altimmune (ALT) Price to Sales (2017 - 2025)
Powered by 
Analysis
Altimmune (ALT) Price to Sales (2017 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Altimmune | 626.80 Mn | 626.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 12,232.92 |
| Sep 30, 2025 | 72,081.39 |
| Jun 30, 2025 | 65,849.05 |
| Mar 31, 2025 | 77,825.45 |
| Dec 31, 2024 | 104,332.60 |
| Sep 30, 2024 | 87,340.77 |
| Jun 30, 2024 | 94,491.54 |
| Mar 31, 2024 | 144,350.64 |
| Dec 31, 2023 | 16,189.95 |
| Sep 30, 2023 | 379.65 |
| Jun 30, 2023 | 30,980.26 |
| Mar 31, 2023 | 9,904.28 |
| Dec 31, 2022 | 31,128.36 |
| Sep 30, 2022 | 313,897.06 |
| Jun 30, 2022 | 67,819.20 |
| Mar 31, 2022 | 8,225.29 |
| Dec 31, 2021 | 114.59 |
| Sep 30, 2021 | 2,842.01 |
| Jun 30, 2021 | 2,853.88 |
| Mar 31, 2021 | 645.08 |